The manufacturers of the 10 initial drugs chosen for Medicare’s price negotiation program have agreed to participate in the historic initiative, the Biden administration said Tuesday.
However, they are not giving up their efforts to overturn the program in court, even after the industry lost its first legal battle on Friday.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased